Pulmonary embolism in pregnancy: Difference between revisions
No edit summary |
|||
| Line 31: | Line 31: | ||
==Sources== | ==Sources== | ||
<references/> | <references/> | ||
[[Category:Pulm]] | |||
[[Category:Cards]] | |||
[[Category:OB/GYN]] | |||
Revision as of 17:07, 7 May 2014
Background
- Also consider V/Q in young females in order to minimize radiation exposure to breast tissue
- Also consider V/Q vs CTPA in pregnant females depending on multiple considerations including the above + radiation burden to fetus
Clinical Features
Differential Diagnosis
Workup
- Clinical features suggestive of PE
- Bilateral LE Ultrasound
- Positive-->treat empirically for PE
- Negative-->CTA
- CT (with shield) vs. V/Q is roughly equilivalent radiation exposure
- Bilateral LE Ultrasound
D-Dimer
- D-Dimer MAY BE (no RCTs) used with following limits:
- 1st trimester: <750 (+50% increase from normal lab threshold)
- 2nd trimester: <1000 (+100% from normal)
- 3rd trimester: <1250 (+150% from normal)
Management
- Heparin and Enoxaparin are safe (coumadin is not)
Disposition
Admit
